Status | Study |
Active, not recruiting |
Study Name: Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients Condition: Proteinuria Idiopathic Membranous Nephropathy Date: 2011-06-29 Interventions: Drug: Repository Corticotropin Injection |
Completed |
Study Name: Influence of Aliskiren on Proteinuria Condition: Chronic Kidney Disease Proteinuria Date: 2010-10-12 Interventions: Drug: Aliskiren, Perindopril Rasilez 300 mg Prestarium 10 mg |
Completed |
Study Name: Rituximab to Prevent Recurrence of Proteinuria Condition: FSGS Proteinuria Date: 2010-07-15 Interventions: Drug: Rituximab Induction therapy Other Name: Rituxa |
Recruiting |
Study Name: Proteinuria in Pre and Post Transplant Condition: Proteinuria Date: 2010-03-25 |
Completed |
Study Name: Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria Condition: HIV Infections Proteinuria Date: 2010-01-06 Interventions: Drug: change from tenofovir to raltegravir Change of the tenofovir based nucleoside part of the HIV regi |
Completed |
Study Name: Prospective Study of TW in the Treatment of LN Type V With Gross Proteinuria Condition: Lupus Nephritis Proteinuria C Date: 2009-07-08 Interventions: Drug: tripterygium glycosides The onset dosage should be 30mg/q.d. and can be reduced into 20mg b.i.d if |
Completed |
Study Name: Study of Prevalence of Proteinuria, Urinary Tract Infection or Hematuria in Athletes Condition: Proteinuria Date: 2009-06-02 |
Completed |
Study Name: The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinuria Condition: Chronic Kidney Disease Proteinuria Date: 2009-03-05 Interventions: Drug: valsartan 160 mg oral once in a day for initial 8 weeks and 320 mg, oral, once in a day for subseq |
Completed |
Study Name: An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2)) Condition: Proteinuria Date: 2007-12-03 Interventions: Drug: Losartan Potassium |
Completed |
Study Name: To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus Condition: Microalbuminuria Proteinuria Date: 2007-10-24 Interventions: Drug: valsartan |